Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Pathologie-Biologie|May 18, 2000
Methodological problems in evaluating efficacy of a treatment in multiple sclerosisE Waubant, D GoodkinRevue Neurologique|June 15, 1999
[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis]E Waubant, R Sloan, P B Andersson, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 2, 2001
IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosisE Waubant, L Gee, K Miller, et al.Neurology|January 15, 2003
IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMSE Waubant, D Goodkin, A Bostrom, et al.Journal of Neuroimmunology|December 8, 2000
Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MSE Waubant, L Gee, P Bacchetti, et al.Neuropediatrics|September 26, 2001
Interferon beta-1a in children with multiple sclerosis is well toleratedE Waubant, J Hietpas, T Stewart, et al.Revue Neurologique|January 15, 2002
[Therapeutic indications for managing symptoms: fatigue]E WaubantMultiple Sclerosis and Related Disorders|February 8, 2018
Multiple sclerosis onset after granulocyte macrophage colony-stimulating factor withdrawalJ Chong, M Cohen, E WaubantPageof 6